# Transcranial stimulation as a possible therapeutic proposal in long COVID

## TL;DR

This paper explores the potential of transcranial stimulation as a treatment for long COVID's neurological symptoms.

## Contribution

It critically reviews current evidence on neuromodulation for managing long COVID symptoms.

## Key findings

- Neuromodulation shows promise for treating refractory neurological symptoms in long COVID.
- Transcranial stimulation could offer new therapeutic perspectives for affected individuals.

## Abstract

The COVID-19 pandemic triggered an unprecedented global health crisis, with significant repercussions on the mental and neurological health of millions of individuals. Long COVID, characterized by persistent and debilitating symptoms, including chronic fatigue, pain, cognitive impairment, and mood swings, represents a substantial therapeutic challenge. In this context, neuromodulation emerges as a promising therapeutic strategy, offering new perspectives for the management of refractory neurological symptoms. This article aims to critically review the current evidence on the use of neuromodulation in patients with long COVID.